Up to now there have been several lawsuits filed against GSK.In one 2004 case GSK settled out of court for $2.5 million dollars for charges of consumer fraud.During the legal discovery process it was uncovered evidence of deliberate, systematic suppression of unfavorable Paxil research results. One of GSK’s internal documents that was found had said, “It would be commercially unacceptable to include a statement that efficacy in children had not been demonstrated, as this would undermine the profile of paroxetine”.
Another recent trial conducted in Philadelphia, a jury awarded $2.5 million in compensatory damages to the family to the plaintiff of the case.The jury in this case was able to award the amount after it was found that GSK “negligently failed to warn” the doctor treating the plaintiff’s mother about the risks of Paxil and the possible birth defects the prescription drug may cause.The mother of the plaintiff admitted that she took Paxil while she was pregnant, and her son, the plaintiff was born with a heart defect. The plaintiff is now 4 years old and recovered from the heart defect he was born with, however, it took several surgeries to repair the heart.
When it was initially classified during its introduction in 1992, as a drug with no known link to increased birth defects.As of now however, after several studies of possible Paxil Birth Defects, Paxil is now categorized as pregnancy category class D. The FDA defines a Class D drug as: “There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.” If you are about to start using Paxil for your signs and symptoms of depression, consult with your doctor first.